(Q44833032)

English

Regulatory effects of interleukin-1beta and prostaglandin E2 on expression of receptor activator of nuclear factor-kappaB ligand in human periodontal ligament cells

scientific article published in February 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Regulatory effects of interleukin-1beta and prostaglandin E2 on expression of receptor activator of nuclear factor-kappaB ligand in human periodontal ligament cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

prostaglandin E2

1 reference

based on heuristic

inferred from title

author name string

Jun Nukaga

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Makoto Kobayashi

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Toshimasa Shinki

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Hong Song

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Takatora Takada

5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Takashi Takiguchi

6

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Ryutarou Kamijo

7

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Kohji Hasegawa

8

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

language of work or name

0 references

publication date

1 February 2004

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Journal of Periodontology

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

75

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

249-259

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Measurement of interleukin-1 alpha and -1 beta in gingival crevicular fluid: implications for the pathogenesis of periodontal disease

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2004.75.2.249

21 January 2018

Levels of interleukin 1 beta in tissue from sites of active periodontal disease

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2004.75.2.249

21 January 2018

Modulation of host PGE2 secretion as a determinant of periodontal disease expression

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2004.75.2.249

21 January 2018

Effects of interleukin-1 on bone turnover in normal mice

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2004.75.2.249

21 January 2018

An interleukin 1 like factor stimulates bone resorption in vitro.

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2004.75.2.249

21 January 2018

Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2004.75.2.249

21 January 2018

Prostaglandin synthesis by fetal rat bone in vitro: Evidence for a role of prostacyclin

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2004.75.2.249

21 January 2018

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2004.75.2.249

21 January 2018

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2004.75.2.249

21 January 2018

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2004.75.2.249

21 January 2018

TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2004.75.2.249

21 January 2018

A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2004.75.2.249

21 January 2018

TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts.

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2004.75.2.249

21 January 2018

Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha,25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2004.75.2.249

21 January 2018

Dual regulation of osteoclast differentiation by periodontal ligament cells through RANKL stimulation and OPG inhibition.

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2004.75.2.249

21 January 2018

Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2004.75.2.249

21 January 2018

Transcriptional induction of cyclooxygenase-2 in osteoblasts is involved in interleukin-6-induced osteoclast formation.

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2004.75.2.249

21 January 2018

The mouse prostaglandin E receptor EP2 subtype: cloning, expression, and northern blot analysis

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2004.75.2.249

21 January 2018

The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2004.75.2.249

21 January 2018

Impaired bone resorption to prostaglandin E2 in prostaglandin E receptor EP4-knockout mice

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2004.75.2.249

21 January 2018

Effects of selective prostaglandin EP4 receptor antagonist on osteoclast formation and bone resorption in vitro

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2004.75.2.249

21 January 2018

Effects of prostaglandin E2 on gene expression in primary osteoblastic cells from prostaglandin receptor knockout mice

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2004.75.2.249

21 January 2018

Human Osteoclast-Like Cells Are Formed from Peripheral Blood Mononuclear Cells in a Coculture with SaOS-2 Cells Transfected with the Parathyroid Hormone (PTH)/PTH-Related Protein Receptor Gene

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2004.75.2.249

21 January 2018

Periodontal ligament cells under mechanical stress induce osteoclastogenesis by receptor activator of nuclear factor kappaB ligand up-regulation via prostaglandin E2 synthesis

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2004.75.2.249

21 January 2018

Prostaglandins up-regulate vascular endothelial growth factor production through distinct pathways in differentiated U937 cells.

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2004.75.2.249

21 January 2018

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2004.75.2.249

21 January 2018

Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2004.75.2.249

21 January 2018

Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2004.75.2.249

21 January 2018

Osteoprotegerin mRNA is increased by interleukin-1 alpha in the human osteosarcoma cell line MG-63 and in human osteoblast-like cells

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2004.75.2.249

21 January 2018

Osteoprotegerin levels increased by interleukin-1beta in human periodontal ligament cells are suppressed through prostaglandin E(2) synthesized de novo

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2004.75.2.249

21 January 2018

Regulation of osteoprotegerin mRNA levels by prostaglandin E2 in human bone marrow stroma cells

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2004.75.2.249

21 January 2018

Intracellular calcium and protein kinase C mediate expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in osteoblasts

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2004.75.2.249

21 January 2018

Regulation of receptor activator of nuclear factor-kappa B ligand and osteoprotegerin mRNA expression by parathyroid hormone is predominantly mediated by the protein kinase a pathway in murine bone marrow cultures

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2004.75.2.249

21 January 2018

Mechanisms of prostaglandin E2-induced interleukin-6 release in astrocytes: possible involvement of EP4-like receptors, p38 mitogen-activated protein kinase and protein kinase C.

1 reference

https://api.crossref.org/works/10.1902%2FJOP.2004.75.2.249

21 January 2018

Identifiers

10.1902/JOP.2004.75.2.249

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44833032&oldid=2048839961"